US Patent 7928103 Compounds which modulate the CB2 receptor
Patent 7928103 was granted and assigned to Boehringer Ingelheim on April, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 15, 2007
0
Date of Patent
April 19, 2011
0
Patent Application Number
12444919
0
Patent Inventor Names
Doris Riether
0
Renee M. Zindell
0
David Smith Thomson
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7928103 Compounds which modulate the CB2 receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.